Cite
HARVARD Citation
Alomari, M. et al. (n.d.). Immune Checkpoint Inhibitors‐Related Gastrointestinal Toxicity Is Associated With Better Overall Survival and Treatment Response in Cancer Patients. American journal of gastroenterology. p. . [Online].